Clinical Trial Update: Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes the use of TheraSphere Yttrium-90 glass microspheres for primary hepatocellular carcinoma and liver metastases, spanning Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Southwestern Regional Medical Center | Conditions: Carcinoma, Hepatocellular, Liver Neoplasms | Phase 1, Phase 2 | Status: COMPLETED